However, its broader impact on appetite and energy balance sets it apart from GHRP-2
Vegetarians are particularly at risk for a carnitine deficiency
Similar patterns appeared in other obesity-related cancers: Non-small cell lung cancer: progression to Stage IV roughly 10% versus 22% Colorectal cancer: statistically significant reduction in progression Hepatocellular (liver) cancer: signal in the same direction A separate JAMA Oncology study by Dai and colleagues (2025), distinct from the Cleveland Clinic ASCO analysis, found about a 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists, with most of the signal coming from skin cancers and obesity-related solid tumors
Others thrive on variety, jumping between roulette, blackjack, and themed slots
Based on Phase 2 data, yes, retatrutide produces more weight loss
Schiepers OJG, Wichers MC, Maes M